Lilly reports first-quarter 2025 financial results and highlights pipeline momentum
HO
Press Releases
Eli Lilly and Company  
May 1, 2025

Lilly reports first-quarter 2025 financial results and highlights pipeline momentum

Revenue in Q1 2025 increased 45% to $12.73 billion driven by volume growth from Mounjaro and Zepbound.Pipeline progress included positive Phase 3 trial results for orforglipron (small molecule oral GLP-1

avatar profile Olean Times Herald

Olean Times Herald


Local & Social